NNVC · AMEX
NanoViricides (NNVC) Stock Price & Fundamentals
NanoViricides (NNVC) closed at $360.49 on Oct 9, 2026, up 0.72% from the previous close of $357.91.
Share price, past year
1Y +31.49%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $360.49 |
| Sep 30, 2026 | $352.80 |
| Aug 31, 2026 | $339.27 |
| Jul 31, 2026 | $322.67 |
| Jun 30, 2026 | $309.85 |
| May 29, 2026 | $295.72 |
| Apr 30, 2026 | $300.48 |
| Mar 31, 2026 | $289.60 |
| Feb 27, 2026 | $289.34 |
| Jan 30, 2026 | $273.85 |
| Dec 31, 2025 | $271.36 |
| Nov 28, 2025 | $278.00 |
| Oct 31, 2025 | $270.33 |
Key statistics
- Market cap
- $8.29B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.41
- Revenue (TTM)
- —
- Net income (TTM)
- −$8.22M
- Shares outstanding
- 23M
- Dividend yield
- —
- 52-week range
- $262.30 – $360.49
NanoViricides's market cap is $8.29B, based on a share price of $360.49 and 23M shares outstanding as of Jun 30, 2026.
Financials
NanoViricides reported revenue of $0.00 for fiscal 2026.
NanoViricides reported a net loss of $8.22M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Jun 30, 2026 | $0.00 | — | −$8.22M | — | −$0.41 | −$7.78M |
| FY2025ended Jun 30, 2025 | $0.00 | — | −$9.47M | — | −$0.63 | −$8.54M |
| FY2024ended Jun 30, 2024 | $0.00 | — | −$8.29M | — | −$0.70 | −$6.47M |
| FY2023ended Jun 30, 2023 | $0.00 | — | −$8.59M | — | −$0.74 | −$5.82M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Sep 30, 2025 | $0.00 | −$1.79M | −$0.10 |
| Q1 FY2025ended Sep 30, 2024 | $0.00 | −$3.13M | −$0.23 |
| Q1 FY2024ended Sep 30, 2023 | $0.00 | — | — |
| Q1 FY2023ended Sep 30, 2022 | $0.00 | — | — |
| Q1 FY2022ended Sep 30, 2021 | $0.00 | — | — |
| Q1 FY2021ended Sep 30, 2020 | $0.00 | — | — |
| Q1 FY2020ended Sep 30, 2019 | $0.00 | — | — |
| Q1 FY2019ended Sep 30, 2018 | $0.00 | — | — |
Company profile
- Name
- NanoViricides, Inc.
- Ticker
- NNVC
- Exchange
- AMEX
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1 Controls Drive, Shelton, CT 06484
- Incorporated in
- DE
- Fiscal year ends
- June
- SEC CIK
- 0001379006
Recent SEC filings
- Sep 29, 2026
- Sep 28, 2026
- Jul 30, 2026
- Jul 17, 2026
- May 21, 2026
- May 20, 2026
- May 15, 2026
- Feb 17, 2026
Frequently asked questions
What is NanoViricides's stock price?
NanoViricides (NNVC) closed at $360.49 on Oct 9, 2026, up 0.72% from the previous close of $357.91.
What is NanoViricides's market cap?
NanoViricides's market cap is $8.29B, based on a share price of $360.49 and 23M shares outstanding as of Jun 30, 2026.
How much revenue does NanoViricides make?
NanoViricides reported revenue of $0.00 for fiscal 2026.
Does NanoViricides pay a dividend?
NanoViricides's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from NanoViricides, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures